Sign in
4

Changes in Ownership

Cogent Biosciences, Inc. Filed Acc 0001209191-20-001889

Options or other derivatives

  • Director acquired 26,480 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ferrante Karen Jean Director 2020-01-02 Grant or award · Stock Option (Right to Buy) +26,480 $0.45 $12,001 26,480 D
Loading xslF345X03/doc4.xml…